CLINICAL_TRIALS
trial_result
· 2018-10-25
Clinical Trial Update: A Study of LY2216684 in Participants With Major Depression Disorder [Phase 3]
Summary
Phase 3 clinical trial update for LY2216684 in participants with Major Depressive Disorder; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-10-25